A method for therapeutic dose selection in a phase II clinical trial using contrast statistics.

Source:http://linkedlifedata.com/resource/pubmed/id/16596575

Stat Med 2007 Feb 10 26 3 498-511

Download in:

View as

Triples

General Info

PMID
16596575